Crossject Société Anonyme (ALCJ.PA)

EUR 2.0

(1.01%)

Operating Expenses Summary of Crossject Société Anonyme

  • Crossject Société Anonyme's latest annual operating expenses in 2023 was 5.66 Million EUR , down -492.64% from previous year.
  • Crossject Société Anonyme's latest quarterly operating expenses in 2024 Q2 was 6 Million EUR , down 0.0% from previous quarter.
  • Crossject Société Anonyme reported a annual operating expenses of -666 Thousand EUR in annual operating expenses 2022, down -168.31% from previous year.
  • Crossject Société Anonyme reported a annual operating expenses of 975 Thousand EUR in annual operating expenses 2021, down -85.96% from previous year.
  • Crossject Société Anonyme reported a quarterly operating expenses of -1.12 Million EUR for 2023 Q2, down 0.0% from previous quarter.
  • Crossject Société Anonyme reported a quarterly operating expenses of -3.94 Million EUR for 2023 FY, down -492.64% from previous quarter.

Annual Operating Expenses Chart of Crossject Société Anonyme (2023 - 2010)

Historical Annual Operating Expenses of Crossject Société Anonyme (2023 - 2010)

Year Operating Expenses Operating Expenses Growth
2023 5.66 Million EUR -492.64%
2022 -666 Thousand EUR -168.31%
2021 975 Thousand EUR -85.96%
2020 6.94 Million EUR 993.98%
2019 -776.68 Thousand EUR -108.59%
2018 9.04 Million EUR 34.6%
2017 6.71 Million EUR 13.13%
2016 5.93 Million EUR 32.71%
2015 4.47 Million EUR 66.06%
2014 2.69 Million EUR 61.13%
2013 1.67 Million EUR -0.36%
2012 1.67 Million EUR -31.63%
2011 2.45 Million EUR -4.75%
2010 2.57 Million EUR 0.0%

Peer Operating Expenses Comparison of Crossject Société Anonyme

Name Operating Expenses Operating Expenses Difference
Safe Orthopaedics SA 10.7 Million EUR 47.081%
Spineway SA 6.06 Million EUR 6.641%
Amplitude Surgical SA 23.96 Million EUR 76.359%
Sartorius Stedim Biotech S.A. 749 Million EUR 99.244%
EssilorLuxottica Société anonyme 12.65 Billion EUR 99.955%
bonyf N.V. 66.3 Thousand EUR -8443.464%